[Epithelial cancer of the ovary: current perspectives. (2)].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007167:Immunotherapy; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D011379:Prognosis; D011837:Radiation-Protective Agents / Q000627:therapeutic use; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use
D004965:Estrogen Antagonists; D011837:Radiation-Protective Agents; D011838:Radiation-Sensitizing Agents
Cáncer epitelial de ovario: perspectivas actuales. (segunda parte).